Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InfuSystem Holdings (INFU) EBIT (2016 - 2025)

Historic EBIT for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $3.8 million.

  • InfuSystem Holdings' EBIT rose 1672.28% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year increase of 9587.33%. This contributed to the annual value of $6.9 million for FY2024, which is 6856.65% up from last year.
  • Per InfuSystem Holdings' latest filing, its EBIT stood at $3.8 million for Q3 2025, which was up 1672.28% from $3.8 million recorded in Q2 2025.
  • InfuSystem Holdings' EBIT's 5-year high stood at $3.8 million during Q3 2025, with a 5-year trough of -$845000.0 in Q1 2024.
  • For the 5-year period, InfuSystem Holdings' EBIT averaged around $1.2 million, with its median value being $1.0 million (2022).
  • In the last 5 years, InfuSystem Holdings' EBIT skyrocketed by 254545.45% in 2021 and then crashed by 68971.96% in 2024.
  • InfuSystem Holdings' EBIT (Quarter) stood at $1.6 million in 2021, then tumbled by 35.77% to $1.0 million in 2022, then increased by 21.48% to $1.2 million in 2023, then skyrocketed by 109.28% to $2.6 million in 2024, then skyrocketed by 45.68% to $3.8 million in 2025.
  • Its EBIT stands at $3.8 million for Q3 2025, versus $3.8 million for Q2 2025 and $618000.0 for Q1 2025.